Inventor · disambiguated record
Derek R. Duckett
Also filed as: DUCKETT DEREK · DUCKETT DEREK R
4 granted patents·8 pending applications·24 citations·filing 2008–2022
65Inventor score
Files withH LEE MOFFITT CANCER CT & RES6SCRIPPS RESEARCH INST4KAMENECKA THEODORE1KAMENECKA THEODORE MARK1
Top patents by PatentIndex Score
12 records- 0185US8530480B2Substituted pyrimidinyl-amines as protein kinase inhibitorsKAMENECKA THEODORE·Filed 2008·Granted Sep 10, 2013·24 cites·15 claims
- 0262US2023303499A1Inhibitors of ack1/tnk2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 0362US2024010634A1Pyrimidinyl sulfonamides as inhibitors of ack1/tnk2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 0458US2020163972A1Therapeutic Targeting of Casein Kinase 1 Delta in Breast CancerSCRIPPS RESEARCH INST·Filed 2019·Application pending·0 cites
- 0557US2024228502A12-phenylamino pyrrolopyrimidines as ack1 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 0655US2025042895A1Inhibitors of ulk1 and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 0754US2025042903A1Triazine inhibitors of cyclin-dependent kinasesH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 0854US2023295129A1Inhibitors of ack1/tnk2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 0951US10603322B2Therapeutic targeting of casein kinase 1δ in breast cancerSCRIPPS RESEARCH INST·Filed 2016·Granted Mar 31, 2020·0 cites·2 claims
- 1050US9018205B2Substituted pyrimidinyl-amines as protein kinase inhibitorsKAMENECKA THEODORE MARK·Filed 2013·Granted Apr 28, 2015·0 cites·10 claims
- 1146US11666578B2Small molecule inhibitors of CDK12/CDK13SCRIPPS RESEARCH INST·Filed 2019·Granted Jun 6, 2023·0 cites·14 claims
- 1242US2015232429A1Substituted pyrimidinyl-amines as protein kinase inhibitorsSCRIPPS RESEARCH INST·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →